AdAlta Limited (ASX: 1AD)
Health Care · Biotechnology · AU
AU$0.00
+14.29% today · 0.0% 1Y
AdAlta Limited (ASX: 1AD) operates in the Biotechnology industry within the Health Care sector. The company is valued at $8.94M and employs 2 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.01.
Tweenvest scores AdAlta Limited across four factors: quality 36/100, value 60/100. Its strongest factor is value.
1AD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $8.94M
- Revenue (TTM)
- $279.66K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.14
- 52-week high
- AU$0.01
- 52-week low
- AU$0.00
- Avg volume (3M)
- —
- Shares outstanding
- 3.21B
- Employees
- 2
- Next earnings
- —
About AdAlta Limited
AdAlta Limited is an Australian-based clinical-stage biotechnology company dedicated to the discovery and development of innovative protein therapeutics. Its leading investigational i-body drug candidate, AD-214, is presently in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis (IPF) and other related fibrotic diseases. The company has forged strategic alliances, including a collaboration with GE Healthcare to identify i-bodies that bind to granzyme B, and a partnership with Carina Biotech Pty Ltd. focused on developing CAR-T cell products designed to target various solid tumor antigens. AdAlta Limited was founded in 2006 and is headquartered in Bundoora, Australia.
- ISIN
- AU0000001AD2
- Founded
- 2006
- Listed since
- Aug 22, 2016
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Spago Nanomedical AB (publ)OM: SPAGO | $9.19M | Skr0.11 | +12.32% |
| BioVie Inc.NasdaqCM: BIVI | $9.05M | $1.20 | -13.67% |
| Hemostemix Inc.TSXV: HEM | $8.97M | CA$0.06 | -20.00% |
| Poxel S.A.ENXTPA: POXEL | $8.95M | €0.15 | +10.45% |
| Biovica International AB (publ)OM: BIOVIC B | $8.90M | Skr0.30 | -0.33% |
| Vistagen Therapeutics, Inc.NasdaqCM: VTGN | $8.88M | $0.20 | -15.29% |
| 1nKemia IUCT Group, S.A.BME: IKM | $8.80M | €— | — |
| Nanologica AB (publ)OM: NICA | $8.66M | Skr0.26 | -5.78% |
Figures last refreshed Oct 18, 2026.